GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CareCloud Inc (NAS:CCLD) » Definitions » 5-Year RORE %

CareCloud (CareCloud) 5-Year RORE % : 38.11% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is CareCloud 5-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. CareCloud's 5-Year RORE % for the quarter that ended in Mar. 2024 was 38.11%.

The industry rank for CareCloud's 5-Year RORE % or its related term are showing as below:

CCLD's 5-Year RORE % is ranked better than
84.86% of 449 companies
in the Healthcare Providers & Services industry
Industry Median: 5.54 vs CCLD: 38.11

CareCloud 5-Year RORE % Historical Data

The historical data trend for CareCloud's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CareCloud 5-Year RORE % Chart

CareCloud Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
5-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.99 18.14 2.01 1.58 44.15

CareCloud Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.51 5.48 12.16 44.15 38.11

Competitive Comparison of CareCloud's 5-Year RORE %

For the Health Information Services subindustry, CareCloud's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CareCloud's 5-Year RORE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CareCloud's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where CareCloud's 5-Year RORE % falls into.



CareCloud 5-Year RORE % Calculation

CareCloud's 5-Year RORE % for the quarter that ended in Mar. 2024 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( -3.85--0.87 )/( -7.82-0 )
=-2.98/-7.82
=38.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2024 and 5-year before.


CareCloud  (NAS:CCLD) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


CareCloud 5-Year RORE % Related Terms

Thank you for viewing the detailed overview of CareCloud's 5-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


CareCloud (CareCloud) Business Description

Traded in Other Exchanges
Address
7 Clyde Road, Somerset, NJ, USA, 08873
CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.
Executives
Mahmud Ul Haq director, 10 percent owner, officer: Chief Executive Officer 7 CLYDE ROAD, SOMERSET NJ 08873
Lawrence Steven Sharnak director 7393, ORANGEWOOD LANE, BOCA RATON FL 33433
Anne Busquet director 390 PARK AVE 4TH FLR, NEW YORK NY 10022
A Hadi Chaudhry officer: President 7 CLYDE ROAD, SOMERSET NJ 08873
Nathalie Grey Garcia officer: General Counsel & Secretary 7 CLYDE ROAD, SOMERSET NJ 08873
Lawrence J. Steenvoorden officer: Chief Financial Officer C/O CHEMBIO DIAGNOSTICS, INC., 555 WIRELESS BOULEVARD, HAUPPAUGE NY 11788
Stephen Andrew Snyder director, officer: President 7 CLYDE ROAD, SOMERSET NJ 08873
Bill Korn officer: Chief Financial Officer 61 DARREN DRIVE, BASKING RIDGE NJ 07920
John N Daly director 390 STANWICH ROAD, GREENWICH CT 06830
Kimberly J Grant officer: General Counsel & Secretary 7 CLYDE ROAD, SOMERSET NJ 08873
Cameron Munter director 295 WEST ORANGE GROVE AVE, SIERRA MADRE CA 91024
Shruti H Patel officer: Interim Corporate Secretary 7 CLYDE ROAD, SOMERSET NJ 08873
Amritpal K. Deol officer: See Remarks 7 CLYDE ROAD, SOMERSET NJ 08873
Norman Roth officer: See Remarks 7 CLYDE ROAD, SOMERSET NJ 08873
Brendan Patrick Harney officer: See Remarks 7 CLYDE ROAD, SOMERSET NJ 08873